Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,2762 USD | +0,44% |
|
-3,43% | -64,77% |
Attività
Numero di dipendenti: 6
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 17/05/23 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Colleen Delaney
CTO | Chief Tech/Sci/R&D Officer | 57 | 30/08/23 |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 62 | 28/10/22 | |
Director/Board Member | 55 | 28/10/22 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Gene Salkind
BRD | Director/Board Member | 70 | 28/10/22 |
Chris Calise
BRD | Director/Board Member | 51 | 28/10/22 |
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Director/Board Member | 56 | 28/10/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 37 118 593 | 25 373 891 ( 68,36 %) | 0 | 68,36 % |
Coordinate società
Coeptis Therapeutics Holdings, Inc.
105 Bradford Road Suite 420
15090, Wexford
+
http://www.coeptistx.com![Indirizzo Coeptis Therapeutics Holdings, Inc.(COEP)](https://cdn.zonebourse.com/static/address/146105655.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-64,77% | 10,25 Mln | |
+54,07% | 809 Mrd | |
+38,95% | 621 Mrd | |
-7,05% | 351 Mrd | |
+15,44% | 319 Mrd | |
+5,72% | 289 Mrd | |
+14,21% | 238 Mrd | |
-0,45% | 221 Mrd | |
+14,58% | 218 Mrd | |
+7,42% | 166 Mrd |
- Borsa valori
- Azioni
- Azione COEP
- Società Coeptis Therapeutics Holdings, Inc.